SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Cyvore emerges from stealth to secure digital workspaces

Romance, lies, and ChatGPT: The scandal shaking Tel Aviv’s startup scene

Trump’s pen cut deep: How a single order derailed Arab tech progress in Israel

“The agent will see you now”: Inside Salesforce Israel’s mission to build responsible AI

More stories 24more

24more

Buzz

Most popular

Daily

Weekly

1

“I don’t want to be the richest man in the cemetery” — Morris Kahn on giving it all away at 95

2

Layoffs loom as Intel’s new CEO moves to fix slow decision-making and chip production

3

From startup exits to psychedelic therapy: Eyal Gura’s new mission

4

"Trump’s behavior is destructive. Americans elected an infantile narcissist, and he is causing enormous harm"

5

The million-dollar draft: How Israeli players are breaking into the NBA—and cashing in

Buzzmore

Protai

2 stories about Protai

Protai Founders

Protai adds $12 million to Seed round as it aims to build oncology drug discovery pipeline

The Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches

Kirill Pevzner and Eran Seger Protai

Protai raises $8 million in Seed for its proteomics-based platform for drug discovery

05.01.22|James Spiro

The company has developed an end-to-end AI-based platform that can map the course of a disease on the protein level